Exo news

The device-agnostic software seamlessly integrates with hospital IT for streamlined documentation, billing and QA management all in one platform

REDWOOD CITY, Calif. (March 9, 2022) — Exo (pronounced “echo”), a pioneering health information and devices company, has unveiled Exo Works™, an intelligent and intuitive point-of-care ultrasound workflow solution that enables physicians to easily document,

Exo continues to be recognized as a pioneer in health information and medical imaging with CB Insights recently naming Exo to its Digital Health 150 List of the most promising, private digital health companies in the world. CB Insights develops software that enables digital health companies to manage end-to-end technology to make decision-making processes more efficient.

“This recognition by CB Insights is deeply rewarding as our company continues to reinvent the way physicians

President of Cardinal Health at-Home, Suzanne Foster, joins Exo board of directors as leadership team also expands.

REDWOOD CITY, Calif. (Nov. 3, 2021) — Following a successful $220 million Series C funding round, pioneering health information and devices company Exo (pronounced “echo”) is expanding its board of directors and adding key industry leaders to its management team to carry out its mission of taking medical imaging everywhere.

Suzanne

Exo will commercialize an affordable handheld ultrasound device and workflow platform for a new era of medical care

REDWOOD CITY, Calif. (July 29, 2021) — Exo (pronounced “echo”), a pioneering health information and devices company, closed a $220 million Series C investment round led by RA Capital Management and joined by BlackRock, Sands Capital, Avidity Partners and Pura Vida Investments that will fund

At the foundation of Exo’s revolutionary imaging technology is a very physical, material-based innovation. As Exo scales its handheld imaging platform across the global healthcare system, a series of loyal company investors have helped both finance and guide Exo’s complex supply chain formation — as well as the overall company vision.

Intel Capital, TDK Ventures, Compal and Applied Ventures, LLC have all been integral to Exo’s development as a full-fledged heal

In the lifecycle of a company from idea to transformative technology innovator, investors play an enormous role. They are not only the financial backing that funds research and development, key hires and product development — they are also a powerful part of the company vision and strategic direction.

Exo is proud to have the support of some of the smartest and most strategic investors on the planet. From leading healthcare investors like RA Capital Management to household names

It’s every startup’s dream to be recognized as a company “worth watching” by publications in their industry. That’s why we are pleased to announce that Electronic Engineering (EE) Times recognized Exo in its Silicon 100: Startups Worth Watching in 2021, a collection of startups across the world changing the game in the semiconductor and electronics industries. Moreover, Exo was named one of the top “Twelve to Delve” startups within the top 100. Featur